US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.34

-0.0500-3.60%

Volume:323.90K

Turnover:443.93K

Market Cap:251.92M

PE:-1.10

High:1.45

Open:1.40

Low:1.33

Close:1.39

52wk High:3.65

52wk Low:0.8302

Shares:188.00M

Float Shares:116.00M

Volume Ratio:0.52

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2237

EPS(LYR):-1.4501

ROE:-187.11%

ROA:-73.85%

PB:5.66

PE(LYR):-0.92

Loading ...

Overview Company News Filings

Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study

MT Newswires Live

Neumora Therapeutics Posts Corporate Presentation on Neuroscience Drug Development Pipeline

Neumora Plans Nmra-215 Clinical Trial in 2026 After Favorable Toxicology Results

Neumora Therapeutics Reports Favorable Nmra-215 Toxicology Results with Planned Clinical Advancement in 2026

THOMSON REUTERS

Neumora Therapeutics - Repeat 13-Week Rat Toxicology Study Shows no Unexpected in-Life Adverse Findings

THOMSON REUTERS

Neumora Therapeutics - Anticipates Initiating Clinical Study for Nmra-215 in 2026

THOMSON REUTERS

Neumora Therapeutics - Plans to Submit Ind Application for Nmra-215 in Q4 2026

THOMSON REUTERS

Neumora Therapeutics is Maintained at Outperform by RBC Capital

RBC Cuts Price Target on Neumora Therapeutics to $5 From $7, Keeps Outperform, Speculative Risk

MT Newswires Live

Neumora Therapeutics Is Maintained at Outperform by Mizuho

Mizuho Adjusts Price Target on Neumora Therapeutics to $4 From $6, Maintains Outperform Rating

MT Newswires Live

Neumora Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright

Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA) and Amgen (AMGN)

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

Sector Update: Healthcare

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

Neumora Halts Navacaprant Development After Phase 3 Depression Trials Miss Primary Endpoints; Shares Fall Pre-Bell

MT Newswires Live

Neumora Therapeutics Scraps Lead Asset Navacaprant After Study Failures

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/NMRA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.34,"timestamp":1788204413771,"preClose":1.39,"halted":0,"volume":323904,"delay":0,"changeRate":-0.03597122302158261,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"Trading","change":-0.05,"latestTime":"08-31 15:26:59 EDT","open":1.4,"high":1.445,"low":1.3305,"amount":443928.70018559997,"amplitude":0.082374,"askPrice":1.35,"askSize":870,"bidPrice":1.34,"bidSize":690,"shortable":3,"etf":0,"ttmEps":-1.223678,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.4913,"preClose":1.39,"latestTime":"09:21 EDT","volume":72,"amount":106.691112,"timestamp":1788182471941,"change":0.1013,"changeRate":0.072878,"amplitude":0.100719},"postHourTrading":{"tag":"盘后","latestPrice":1.4085,"preClose":1.39,"latestTime":"19:31 EDT","volume":4741,"amount":6639.217,"timestamp":1787959906559,"change":0.0185,"changeRate":0.013309,"amplitude":0.021583},"volumeRatio":0.520748,"impliedVol":1.5034,"impliedVolPercentile":0.5976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":115999999,"roa":"-73.85%","roe":"-187.11%","lyrEps":-1.450067,"volumeRatio":0.520748,"shares":188000000,"dividePrice":0,"high":1.445,"amplitude":0.082374,"preClose":1.39,"low":1.3305,"week52Low":0.83015,"pbRate":"5.66","week52High":3.65,"institutionHeld":0,"latestPrice":1.34,"committee":-0.115385,"eps":-1.223678,"divideRate":0,"volume":323904,"delay":0,"ttmEps":-1.223678,"open":1.4,"prevYearClose":1.79,"prevWeekClose":1.39,"prevMonthClose":1.61,"prevQuarterClose":1.7,"fiveDayClose":1.525,"twentyDayClose":1.64,"sixtyDayClose":1.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"NMRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.23,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-07","symbol":"NMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-03-30","symbol":"NMRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-11-06","symbol":"NMRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-06","symbol":"NMRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2026-08-28","current":-1.095059,"percent":0.696629,"low":-19.620035,"twenty":-8.561179,"median":-1.728093,"eighty":-1.072157,"high":-0.385538,"avg":-4.815546,"sd":4.91964,"marketCap":278085949},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-27","current":-0.501055,"twenty":-11.897527,"median":-6.552046,"eighty":-0.939895,"marketCap":129301288},{"date":"2025-07-03","current":-0.51497,"twenty":-11.882746,"median":-6.531197,"eighty":-0.932192,"marketCap":132892092},{"date":"2025-07-11","current":-0.664396,"twenty":-11.845391,"median":-6.513687,"eighty":-0.915408,"marketCap":171452797},{"date":"2025-07-18","current":-1.071809,"twenty":-11.813935,"median":-6.466558,"eighty":-0.901766,"marketCap":276588946},{"date":"2025-07-25","current":-1.435347,"twenty":-11.800172,"median":-6.430581,"eighty":-0.91143,"marketCap":370402741},{"date":"2025-08-01","current":-1.228506,"twenty":-11.772648,"median":-6.345689,"eighty":-0.913154,"marketCap":317025927},{"date":"2025-08-08","current":-1.05869,"twenty":-11.733327,"median":-6.279953,"eighty":-0.915408,"marketCap":266884071},{"date":"2025-08-15","current":-1.015014,"twenty":-11.717599,"median":-6.27111,"eighty":-0.917957,"marketCap":255873774},{"date":"2025-08-22","current":-1.053558,"twenty":-11.711701,"median":-6.248553,"eighty":-0.922507,"marketCap":265590500},{"date":"2025-08-29","current":-1.130648,"twenty":-11.697847,"median":-6.240161,"eighty":-0.927824,"marketCap":285023951},{"date":"2025-09-05","current":-1.047134,"twenty":-11.691098,"median":-6.234271,"eighty":-0.929873,"marketCap":263971046},{"date":"2025-09-12","current":-1.066407,"twenty":-11.688352,"median":-6.217154,"eighty":-0.931528,"marketCap":268829408},{"date":"2025-09-19","current":-1.00859,"twenty":-11.674168,"median":-6.167847,"eighty":-0.932308,"marketCap":254254320},{"date":"2025-09-26","current":-1.092103,"twenty":-11.654686,"median":-6.150338,"eighty":-0.934175,"marketCap":275307225},{"date":"2025-10-03","current":-1.143496,"twenty":-11.648787,"median":-6.138654,"eighty":-0.935832,"marketCap":288262860},{"date":"2025-10-10","current":-1.252707,"twenty":-11.625195,"median":-6.129234,"eighty":-0.937276,"marketCap":315793582},{"date":"2025-10-17","current":-1.143496,"twenty":-11.585874,"median":-6.098338,"eighty":-0.939018,"marketCap":288262860},{"date":"2025-10-24","current":-1.483976,"twenty":-11.573312,"median":-6.085275,"eighty":-0.940658,"marketCap":374093936},{"date":"2025-10-31","current":-1.882272,"twenty":-11.535481,"median":-6.072715,"eighty":-0.944448,"marketCap":474500101},{"date":"2025-11-07","current":-1.768195,"twenty":-11.493728,"median":-6.047595,"eighty":-0.950132,"marketCap":417819201},{"date":"2025-11-14","current":-1.902139,"twenty":-11.492838,"median":-5.97813,"eighty":-0.950743,"marketCap":449469716},{"date":"2025-11-21","current":-1.668791,"twenty":-11.473837,"median":-5.972235,"eighty":-0.95386,"marketCap":394330309},{"date":"2025-11-28","current":-1.583937,"twenty":-11.438475,"median":-5.963003,"eighty":-0.958453,"marketCap":374279615},{"date":"2025-12-05","current":-1.608686,"twenty":-11.3991,"median":-5.921482,"eighty":-0.963621,"marketCap":380127734},{"date":"2025-12-12","current":-1.488688,"twenty":-11.349949,"median":-5.869128,"eighty":-0.966191,"marketCap":351772572},{"date":"2025-12-19","current":-1.236978,"twenty":-11.209123,"median":-5.84706,"eighty":-0.976733,"marketCap":292294118},{"date":"2025-12-26","current":-1.301703,"twenty":-11.180579,"median":-5.82548,"eighty":-0.977791,"marketCap":307588578},{"date":"2026-01-02","current":-1.28732,"twenty":-10.823503,"median":-5.782265,"eighty":-0.97889,"marketCap":304189809},{"date":"2026-01-09","current":-1.675673,"twenty":-10.734234,"median":-5.771277,"eighty":-0.987831,"marketCap":395956567},{"date":"2026-01-16","current":-1.531839,"twenty":-10.632004,"median":-5.730809,"eighty":-0.990132,"marketCap":361968879},{"date":"2026-01-23","current":-1.510263,"twenty":-10.51228,"median":-5.690707,"eighty":-0.994023,"marketCap":356870726},{"date":"2026-01-30","current":-1.474305,"twenty":-10.431808,"median":-5.626838,"eighty":-0.999937,"marketCap":348373804},{"date":"2026-02-06","current":-1.409579,"twenty":-10.281677,"median":-5.512839,"eighty":-1.00602,"marketCap":333079344},{"date":"2026-02-13","current":-2.337313,"twenty":-10.17329,"median":-5.423912,"eighty":-1.009395,"marketCap":552299933},{"date":"2026-02-20","current":-2.502722,"twenty":-10.087087,"median":-5.390906,"eighty":-1.011964,"marketCap":591385774},{"date":"2026-02-27","current":-2.553064,"twenty":-9.944314,"median":-5.374404,"eighty":-1.018277,"marketCap":603281465},{"date":"2026-03-06","current":-2.157519,"twenty":-9.899493,"median":-5.330396,"eighty":-1.027437,"marketCap":509815323},{"date":"2026-03-13","current":-2.258203,"twenty":-9.891226,"median":-5.316643,"eighty":-1.03397,"marketCap":533606704},{"date":"2026-03-20","current":-1.848275,"twenty":-9.844641,"median":-2.553064,"eighty":-1.034185,"marketCap":436741793},{"date":"2026-03-27","current":-1.790741,"twenty":-9.769472,"median":-2.506318,"eighty":-1.034236,"marketCap":423146718},{"date":"2026-04-02","current":-1.605828,"twenty":-9.718546,"median":-2.484743,"eighty":-1.034286,"marketCap":380465575},{"date":"2026-04-10","current":-1.598144,"twenty":-9.645471,"median":-2.437997,"eighty":-1.035523,"marketCap":378645165},{"date":"2026-04-17","current":-1.536677,"twenty":-9.606931,"median":-2.340909,"eighty":-1.040518,"marketCap":364081890},{"date":"2026-04-24","current":-1.719486,"twenty":-9.518687,"median":-2.301354,"eighty":-1.04071,"marketCap":407394409},{"date":"2026-05-01","current":-1.904543,"twenty":-9.445953,"median":-2.229437,"eighty":-1.041995,"marketCap":451239547},{"date":"2026-05-08","current":-1.495876,"twenty":-9.432484,"median":-2.171903,"eighty":-1.047134,"marketCap":354414867},{"date":"2026-05-15","current":-1.618279,"twenty":-9.420361,"median":-2.157519,"eighty":-1.047134,"marketCap":359895509},{"date":"2026-05-22","current":-1.519703,"twenty":-9.409586,"median":-2.064027,"eighty":-1.047134,"marketCap":337972940},{"date":"2026-05-29","current":-1.544347,"twenty":-9.388035,"median":-2.022348,"eighty":-1.047134,"marketCap":343453582},{"date":"2026-06-05","current":-1.437557,"twenty":-9.385312,"median":-1.929745,"eighty":-1.050677,"marketCap":319704133},{"date":"2026-06-12","current":-1.48298,"twenty":-9.273547,"median":-1.902139,"eighty":-1.053558,"marketCap":329805954},{"date":"2026-06-18","current":-1.274697,"twenty":-9.262772,"median":-1.884704,"eighty":-1.052982,"marketCap":283484893},{"date":"2026-06-26","current":-1.258034,"twenty":-9.249303,"median":-1.881168,"eighty":-1.053558,"marketCap":279779208},{"date":"2026-07-02","current":-1.349679,"twenty":-9.177916,"median":-1.861064,"eighty":-1.05513,"marketCap":300160475},{"date":"2026-07-10","current":-1.374673,"twenty":-9.115941,"median":-1.805124,"eighty":-1.057685,"marketCap":305719002},{"date":"2026-07-17","current":-1.333016,"twenty":-9.073636,"median":-1.796333,"eighty":-1.060483,"marketCap":296454790},{"date":"2026-07-24","current":-1.299691,"twenty":-9.014102,"median":-1.790741,"eighty":-1.061679,"marketCap":289043420},{"date":"2026-07-31","current":-1.374673,"twenty":-8.975861,"median":-1.781172,"eighty":-1.06357,"marketCap":305719002},{"date":"2026-08-07","current":-1.366342,"twenty":-8.932776,"median":-1.776358,"eighty":-1.066407,"marketCap":303866160},{"date":"2026-08-14","current":-1.441324,"twenty":-8.783796,"median":-1.768195,"eighty":-1.066716,"marketCap":320541742},{"date":"2026-08-21","current":-1.338045,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"marketCap":284662306},{"date":"2026-08-28","current":-1.307133,"twenty":-8.561179,"median":-1.728093,"eighty":-1.072157,"marketCap":278085949}],"updateTime":1788204419980},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654010397","title":"Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010397","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010397?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:21","pubTimestamp":1785154877,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics  said Monday a repeat safety study of its experimental oral obesity drug, NMRA-215, found no unexpected in-life adverse findings, supporting plans to file an investigational new drug application in the fourth quarter of 2026.The company said it repeated the 13-week rat study after an earlier study reported unexpected findings in five of 142 animals.Neumora said an audit found discrepancies that resulted in critical audit observations in how the earlier study was conducted, and the new results, along with previous studies in rats and dogs, suggest the earlier findings were not caused by NMRA-215.Neumora said its preclinical studies showed NMRA-215 produced weight loss as a monotherapy, increased weight loss when used with semaglutide, and improved markers linked to heart and metabolic health.It added that it expects to begin a Phase 1 clinical trial by the end of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND","BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014512","title":"Neumora Therapeutics Posts Corporate Presentation on Neuroscience Drug Development Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014512?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:03","pubTimestamp":1785150210,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics posts corporate presentation on neuroscience drug development pipelineNeumora outlined three lead programs across cardiometabolic, neurodegenerative, neuropsychiatric disease, anc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDLbPygLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654301439","title":"Neumora Plans Nmra-215 Clinical Trial in 2026 After Favorable Toxicology Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654301439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654301439?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150022,"startTime":"0","endTime":"0","summary":"Neumora plans NMRA-215 clinical trial in 2026 after favorable toxicology resultsNeumora reported favorable preclinical toxicology results for NMRA-215, supporting plans to move the oral obesity and ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL3lyxY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","NDAQ","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","NMRA","IE00BGHQF748.EUR","LU0314104364.USD","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654101482","title":"Neumora Therapeutics Reports Favorable Nmra-215 Toxicology Results with Planned Clinical Advancement in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654101482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654101482?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUAYTB5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014826","title":"Neumora Therapeutics - Repeat 13-Week Rat Toxicology Study Shows no Unexpected in-Life Adverse Findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014826?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUAYTB5R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014803","title":"Neumora Therapeutics - Anticipates Initiating Clinical Study for Nmra-215 in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014803?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUAYTB5R:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014386","title":"Neumora Therapeutics - Plans to Submit Ind Application for Nmra-215 in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014386?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUAYTB5R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117978","title":"Neumora Therapeutics is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117978?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:19","pubTimestamp":1783952340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 10:19 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651191113","title":"RBC Cuts Price Target on Neumora Therapeutics to $5 From $7, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651191113","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651191113?lang=en_us&edition=fundamental","pubTime":"2026-07-13 18:30","pubTimestamp":1783938658,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644038450","title":"Neumora Therapeutics Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2644038450","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644038450?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:53","pubTimestamp":1781805180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 13:53 ET (17:53 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MFG","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644198083","title":"Mizuho Adjusts Price Target on Neumora Therapeutics to $4 From $6, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2644198083","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644198083?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:13","pubTimestamp":1781784786,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643756891","title":"Neumora Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2643756891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643756891?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:26","pubTimestamp":1781605560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 06:26 ET (10:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755205","title":"Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643755205?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:11","pubTimestamp":1781604679,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Neumora Therapeutics (NMRA) to $7 from $18 and keeps a Buy rating on the shares after the compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-price-target-lowered-to-7-from-18-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-price-target-lowered-to-7-from-18-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643078157","title":"Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2643078157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643078157?lang=en_us&edition=fundamental","pubTime":"2026-06-16 06:30","pubTimestamp":1781562609,"startTime":"0","endTime":"0","summary":"Clear Street keeps a Buy rating and a $45 price target on LB Pharmaceuticals (LBRX). The firm contends that Neumora Therapeutics (NMRA) Phase 3 KOA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clear-street-says-neumora-failed-trial-does-not-impact-lb-pharmaceuticals-lb-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clear-street-says-neumora-failed-trial-does-not-impact-lb-pharmaceuticals-lb-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LBRX","BK4007","BK4213","LB","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643789319","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643789319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643789319?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:00","pubTimestamp":1781557224,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neumora Therapeutics, Inc. (NMRA) and Amgen (AMGN). Neumora Thera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neumora-therapeutics-inc-nmra-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neumora-therapeutics-inc-nmra-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LU1023059063.AUD","LU0320765992.SGD","BK4533","BK4566","IE0002141913.USD","BK4007","IE00BJJMRZ35.SGD","LU0128526141.USD","LU0889565916.HKD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","LU2242646821.SGD","BK4534","BK4599","LU1061106388.HKD","IE00B2B36J28.USD","LU0029874061.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","BK4585","XBI","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2112291526.USD","XLV","LU0122379950.USD","HCSG","LABU","LU1983299246.USD","SG9999001440.SGD","BK4137","AMGN","LU0868494617.USD","BK4139","LU0109394709.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643019200","title":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2643019200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643019200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:13","pubTimestamp":1781547236,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, PaychexWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL6N42N0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHAZ","FOXA","LXEO","DAL","CONY","SNK","CVX","XOMX","PTRN","XOMO","LCLN","ELTX","LUV","PTCT","MU","NCLH","RIOT","COIN","APA","FISV","UAL","CMTL","ICOI","MRAL","BAND","SCCO","RCL","NMRA","TRAW","SPCU","CCL","COII","HUT","FCX","MUU","XOM","ABNY","ABNB","OXY","AAL","COYY","PSKY","SPCX","COIW","DDOG","MARA","TRIP","CONI","NEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643207276","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2643207276","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643207276?lang=en_us&edition=fundamental","pubTime":"2026-06-16 01:13","pubTimestamp":1781543591,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Monday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF  shedding 0.5%.The iShares Biotechnology ETF  rose 0.7%.In corporate news, Neumora Therapeutics  shares fell 48% after the firm said Monday it is discontinuing development of its major depressive disorder treatment navacaprant after two phase 3 trials failed to meet their primary and key secondary endpoints.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","IBB","LU0128526141.USD","XBI","BK4007","NMRA","BK4137","BK4581","LABU","LU0029874061.USD","BK4585","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643383202","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2643383202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643383202?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:30","pubTimestamp":1781537410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neumora Therapeutics, Inc. (NMRA) and IDEAYA Bioscie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-226?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-226?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643520544","title":"Neumora Halts Navacaprant Development After Phase 3 Depression Trials Miss Primary Endpoints; Shares Fall Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2643520544","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643520544?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:50","pubTimestamp":1781527826,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics  said Monday it is discontinuing development of its experimental major depressive disorder treatment navacaprant after two phase 3 studies failed to meet their primary and key secondary endpoints.The KOASTAL-2 and KOASTAL-3 trials, which enrolled more than 850 patients combined, did not show a statistically significant improvement over placebo on the Montgomery-Asberg Depression Rating Scale after six weeks of treatment.The company said pre-specified analyses of patients enrolled after study optimizations in early 2025 also failed to demonstrate efficacy.Following the setback, Neumora announced plans to reduce its workforce by about 35%, a move expected to generate annualized cost savings of roughly $10 million.The company said it expects existing cash reserves to fund operations into Q3 of 2027.Shares of Neumora fell more than 51% in recent premarket activity Monday.Price: 0.86, Change: -0.91, Percent Change: -51.40","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205965","title":"Neumora Therapeutics Scraps Lead Asset Navacaprant After Study Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205965","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205965?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:40","pubTimestamp":1781527200,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics is throwing in the towel on navacaprant following the failure of its lead drug candidate in a pair of late-stage studies.Neumora on Monday said navacaprant didn't achieve statistical significance on the primary or key secondary endpoints in two Phase 3 studies in major depressive disorder.The Watertown, Mass., clinical-stage biopharmaceutical company said it plans to slash 35% of its workforce as it focuses on advancing the rest of its portfolio.Neumora said it expects the job cuts to result in $10 million of annual savings, adding that its current cash and equivalents provide a runway into the third quarter of 2027.Trading in shares of Neumora, which closed Friday at $1.78, was halted premarket on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","DBB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":95,"code":"91000000","status":"200"}]}}